ArticlePlants (Basel, Switzerland)2026
Pyroxsulam Boosts Wheat Tolerance to Bixlozone: Effects and Mechanisms.
Article in Plants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Bixlozone has significant potential as a pre-emergence and early post-emergence herbicide in wheat production across China. However, its safety when applied to wheat is poor, frequently causing phytotoxicity. This study confirmed the capacity of pyroxsulam to mitigate bixlozone-induced injury without compromising weed control efficacy and examined the underlying processes. Wheat exposed to bixlozone alone developed pronounced chlorosis and significant reductions in tiller formation, ultimately lowering the grain yield. In contrast, co-treatment with pyroxsulam substantially relieved chlorosis and restored both the tiller number and yield performance. Bixlozone reduced chlorophyll and carotenoid levels, impairing the function of photosystem II (PSII), which was mitigated by pyroxsulam application. Transcriptome profiling showed that pyroxsulam strongly activated detoxification-related pathways, especially those associated with glutathione S-transferases (GSTs) and ATP-binding cassette (ABC) transporters, which facilitate the metabolic detoxification or compartmentalization of bixlozone. qRT-PCR further validated the marked induction of key detoxification genes
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.